Cargando…

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy

Lung cancer is the leading cause of cancer death in U.S. and represents a major public health burden. Epidemiologic data have suggested that lung cancer in women may possess different biological characteristics compared to men, as evidenced by a higher proportion of never-smokers among women with lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baik, Christina S., Eaton, Keith D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712734/ https://www.ncbi.nlm.nih.gov/pubmed/24213497 http://dx.doi.org/10.3390/cancers4040969

Ejemplares similares

Estrogen, Estrogen Receptor and Lung Cancer
por: Hsu, Li-Han, et al.
Publicado: (2017)

Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung Cancer
por: Musial, Claudia, et al.
Publicado: (2021)

Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer
por: Oria, Victor Oginga, et al.
Publicado: (2023)

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
por: Mann, Monica, et al.
Publicado: (2011)

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
por: Langdon, Simon P., et al.
Publicado: (2020)

Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
por: Jablonska, Paola Anna, et al.
Publicado: (2021)

Exploring estrogenic activity in lung cancer
por: Słowikowski, Bartosz Kazimierz, et al.
Publicado: (2016)

Estrogen Receptor Signaling in Breast Cancer
por: Miziak, Paulina, et al.
Publicado: (2023)

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
por: Yang, Han, et al.
Publicado: (2023)

Estrogen rapid effects: a window of opportunity for the aging brain?
por: Marchant, Ivanny, et al.
Publicado: (2022)

HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
por: Uy, Natalie F., et al.
Publicado: (2022)

Molecular mechanism of estrogen–estrogen receptor signaling
por: Yaşar, Pelin, et al.
Publicado: (2016)

Epigenetic regulation of estrogen signaling in breast cancer
por: Hervouet, Eric, et al.
Publicado: (2013)

Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
por: Ozyurt, Rumeysa, et al.
Publicado: (2022)

Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges
por: Chen, Yuchen, et al.
Publicado: (2018)

Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy
por: Lawless, Matthew W, et al.
Publicado: (2009)

Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2023)

Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
por: Gu, Jian-Wei, et al.
Publicado: (2012)

Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways
por: Zhao, Xiao-zhen, et al.
Publicado: (2015)

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
por: Iorga, Andrea, et al.
Publicado: (2017)

Current and novel therapeutic opportunities for systemic therapy in biliary cancer
por: Marin, José J. G., et al.
Publicado: (2020)

Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
por: Xu, Caili, et al.
Publicado: (2022)

The many faces of estrogen signaling
por: Vrtačnik, Peter, et al.
Publicado: (2014)

S1P signaling: new therapies and opportunities
por: Gonzalez-Cabrera, Pedro J., et al.
Publicado: (2014)

Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
por: Davalli, Pierpaola, et al.
Publicado: (2018)

Immunometabolic Links between Estrogen, Adipose Tissue and Female Reproductive Metabolism
por: Eaton, Sally A., et al.
Publicado: (2019)

Estrogens in schizophrenia: progress, current challenges and opportunities
por: Brand, Bodyl A., et al.
Publicado: (2021)

The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers
por: James, Claire D., et al.
Publicado: (2020)

Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective
por: Maitra, Radhashree, et al.
Publicado: (2021)

Emerging Roles of Estrogen-Related Receptors in the Brain: Potential Interactions with Estrogen Signaling
por: Saito, Kenji, et al.
Publicado: (2018)

Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
por: Saha Roy, Sudipa, et al.
Publicado: (2012)

Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer
por: Lau, Kin-Mang, et al.
Publicado: (2016)

A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
por: Park, Woo-Jung, et al.
Publicado: (2023)

Estrogen Signaling in Metabolic Inflammation
por: Monteiro, Rosário, et al.
Publicado: (2014)

Opportunities and Challenges of Kava in Lung Cancer Prevention
por: Freeman, Breanne, et al.
Publicado: (2023)

MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies
por: Rivas, Solange, et al.
Publicado: (2022)

Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy
por: Treeck, Oliver
Publicado: (2023)

Estrogen Receptor Signaling in Cancer
por: Langdon, Simon P.
Publicado: (2020)

Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer
por: Liu, Jian, et al.
Publicado: (2021)

A Novel Prodrug Approach for Central Nervous System-Selective Estrogen Therapy
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3b7cv31miolfbc8diaru5eskru